首页> 外文期刊>Expert opinion on investigational drugs >Neurotensin agonists as an alternative to antipsychotics
【24h】

Neurotensin agonists as an alternative to antipsychotics

机译:神经降压素激动剂可替代抗精神病药

获取原文
获取原文并翻译 | 示例
       

摘要

Neurotensin (NT) is a 13 amino acid neuropeptide that is found in the central nervous system and in the gastrointestinal tract.In brain,this peptide is prominently associated anatomically with dopaminergic,as well as other neurotransmitter systems.Based on animal studies,already decades old,researchers have hypothesised that NT receptor agonists will have antipsychotic properties in patients.However,to date no one has obtained a non-peptide NT receptor agonist.Therefore,there has been great interest in obtaining peptide analogues of NT,that,unlike NT resist degradation by peptidases and cross the blood-brain barrier,yet have the pharmacological characteristics of native NT,for therapeutic use in the treatment of schizophrenia,as well as other neuropsychiatric diseases such as Parkinson's disease and addiction to psychostimulants.In this review,we present the rationale for development of NT receptor agonists for treatment of certain central nervous system diseases,as well as a review of those peptide agonists that are in early stages of development.
机译:神经降压素(NT)是一种13个氨基酸的神经肽,存在于中枢神经系统和胃肠道中。在大脑中,该肽在解剖学上与多巴胺能以及其他神经递质系统显着相关。基于动物研究,已有数十年的历史了过去,研究人员假设NT受体激动剂对患者具有抗精神病作用。然而,迄今为止,还没有人获得非肽NT受体激动剂。因此,人们对获得NT的肽类似物非常感兴趣,这与NT不同抵抗肽酶降解并穿越血脑屏障,但仍具有天然NT的药理特性,可用于治疗精神分裂症以及帕金森氏病和成瘾性精神兴奋药等其他神经精神疾病。介绍开发用于治疗某些中枢神经系统疾病的NT受体激动剂的基本原理,以及对那些处于发展初期的肽激动剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号